CLINICAL AND BIOLOGICAL EVALUATION OF THE NOVEL CD30/CD16A TETRAVALENT BISPECIFIC ANTIBODY (AFM13) IN RELAPSED OR REFRACTORY CD30‐POSITIVE LYMPHOMA WITH CUTANEOUS PRESENTATION: A B... by Sawas, A., Chen, P., Vlad, G., Lipschitz, M., Abdul‐Hay, M., Lue, J., Deng, C., Amengual, J.E., Marchi, E., Shulman, J., Elgedawe, H., Shong, M.V., Khan, K., Geskin, L., Rodig, S.J., O'Connor, O.

Get full text

TARGETING THE PERIPHERAL T‐CELL LYMPHOMA (PTCL) EPIGENOME WITH ORAL 5‐AZACYTIDINE AND ROMIDEPSIN: RESULTS AND CLINICAL‐MOLECULAR CORRELATIONS FROM A PHASE 2 STUDY by Falchi, L., Lue, J.K., Montanari, F., Marchi, E., Amengual, J.E., Sawas, A., Deng, C., Khan, K., Kim, H.A., Rada, A., Malanga, M., Francescone, M.F., Soderquist, C.R., Park, D.C., Bhagat, G., Sokol, L., Shustov, A.R., O'Connor, O.A.

Get full text

DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS by Lue, J.K., Prabhu, S.A., Liu, Y., Verma, A., Elemento, O., Amengual, J.E.

Get full text

A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL) by Amengual, J.E., Lichtenstein, R., Lue, J.K., Sawas, A., Deng, C., Lichtenstein, E., Khan, K., Kim, H., Atkins, L., Turenne, I., Rojas, C., Chiuzan, C., Cremers, S., O'Connor, O.A.

Get full text

ORAL AZACYTIDINE (AZA) AND ROMIDEPSIN (R) REVEALS PROMISING ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL) by O'Connor, O.A., Lue, J.K., Amengual, J.E., Sawas, A., Deng, C., Lichtenstein, E., Khan, K., Kim, H., Atkins, L., Rada, A., Rojas, C., Cremers, S.

Get full text